CSIMarket
 




Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 
 



KYMR Price to Sales Ratio (Mar 31 2022) (Sep 30 2021) (Jun 30 2021) (Mar 31 2021) (Dec 31 2020)
Sales Trailing 12 Months I. Quarter III. Quarter II. Quarter I. Quarter IV. Quarter
Price to Sales (TTM) Ratio current            30.36            69.27            59.08            59.08            59.08
Revenue TTM Y / Y Change - % - % - % - % - %
Revenue Y / Y Change -48.55 % - % - % - % - %
Stock performance to date -11.83 % -1.22 % 37.55 % -24.07 %

Price to sales ratio Comment
Company's current Price to sales ratio has decreased due to shareprice contraction of -11.83 %, from beginning of I. Quarter and due to Revenue increase, to Price to Sales of 30.36, from average Price to sales ratio in III. Quarter of 69.27.

Within Healthcare sector 35 other companies have lower Price to sales ratio.

What is Price to Sales Ratio?
Sales growth by Kymera Therapeutics Inc Segment

Price to sales ratio Company Ranking
Within: No.
Industry #4
Sector #36
S&P 500 #555






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com